Vetoquinol | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
23,585.00
25,772.00
24,160.00
27,830.00
34,838.00
36,226
Depreciation, Depletion & Amortization
11,568.00
12,845.00
13,189.00
14,153.00
12,220.00
12,838
Other Funds
671.00
15.00
-
1.00
776.00
49
Funds from Operations
34,482.00
39,855.00
40,916.00
45,444.00
39,943.00
48,815
Changes in Working Capital
6,376.00
2,417.00
1,293.00
1,781.00
1,258.00
10,909
Net Operating Cash Flow
28,106.00
42,272.00
39,623.00
43,663.00
41,201.00
37,906
Capital Expenditures
7,540.00
11,200.00
13,522.00
13,595.00
13,705.00
Sale of Fixed Assets & Businesses
137.00
351.00
419.00
720.00
596.00
Purchase/Sale of Investments
-
24.00
-
544.00
1,124.00
Net Investing Cash Flow
7,689.00
52,244.00
15,259.00
13,419.00
15,683.00
Cash Dividends Paid - Total
4,139.00
4,383.00
4,627.00
4,860.00
5,098.00
Issuance/Reduction of Debt, Net
10,568.00
29,701.00
19,112.00
8,961.00
-
Net Financing Cash Flow
14,021.00
26,241.00
23,739.00
14,208.00
14,545.00
Net Change in Cash
4,937.00
17,263.00
877.00
16,223.00
9,727.00
Free Cash Flow
21,634.00
32,035.00
28,607.00
34,223.00
30,119.00
Deferred Taxes & Investment Tax Credit
-
1,494.00
-
-
3,966.00
298
Net Assets from Acquisitions
165.00
41,419.00
2,136.00
-
1,450.00
Change in Capital Stock
15.00
938.00
-
386.00
-
Exchange Rate Effect
1,459.00
994.00
252.00
187.00
1,246.00
Other Uses
121.00
-
20.00
-
-

About Vetoquinol

View Profile
Address
34, rue du Chêne Sainte-Anne
Lure Franche-Comte 70200
France
Employees -
Website http://www.vetoquinol.com
Updated 07/08/2019
Vétoquinol SA engages in designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific regions. It is a player in the animal health sector serving both the livestock such as cattle and pigs and pet dogs and cats markets. The company operates through the following segments: Europe, Americas, and Asia Pacific and Rest of the World.